Who owns the DESIGNING THE FUTURE IN PHARMACEUTICALS trademark?

The DESIGNING THE FUTURE IN PHARMACEUTICALS trademark is owned by Genzyme Corporation.

What class is the DESIGNING THE FUTURE IN PHARMACEUTICALS trademark registered in?

The DESIGNING THE FUTURE IN PHARMACEUTICALS trademark is registered in Class 042 (Scientific, technology & SaaS services).

What is the serial number for DESIGNING THE FUTURE IN PHARMACEUTICALS?

The USPTO serial number for DESIGNING THE FUTURE IN PHARMACEUTICALS is 75032818.

What is the registration number for DESIGNING THE FUTURE IN PHARMACEUTICALS?

DESIGNING THE FUTURE IN PHARMACEUTICALS is registered under USPTO registration number 2136551.

DES

USPTO Trademark Record

ABANDONED

DESIGNING THE FUTURE IN PHARMACEUTICALS

SN 75032818·Reg 2136551·Filed Dec 14, 1995

Owner Genzyme Corporation

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

DESIGNING THE FUTURE IN PHARMACEUTICALS (Serial No. 75032818), Registration No. 2136551, is a abandoned US trademark filed on Dec 14, 1995 by Genzyme Corporation. This trademark covers Class 042 (Scientific, technology & SaaS services).

Mark Intelligence

DESIGNING THE FUTURE IN PHARMACEUTICALS (Reg. #2136551) is an abandoned US trademark that was filed in 1995 but has since been abandoned. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 1 opposition proceeding during prosecution.

FILED

Dec 14, 1995

SERIAL

75032818

REG#

2136551

REGISTERED

Feb 17, 1998

Owner

Applicant

Genzyme Corporation

Entity

Corporation

State

Address

One Kendall Square, Cambridge, MA, 02139

Country

Attorney

NameWilliam G. Gosz

Law firm

LEGAL DEPT GENZYME CORPORATION

Address

15 PLEASANT ST CONNECTOR, FRAMINGHAM, MA 01701-9322, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusABANDONED

Filing DateDec 14, 1995

Serial Number75032818

Registration No.2136551

Registration DateFeb 17, 1998

Status DateNov 21, 2008

Published for OppositionNov 25, 1997

Mark TypeTypeset (words/letters/numbers)

Status DescriptionDead and cancelled, Section 8

Filing Signals

FILED

1995

YEARS AGO

31y

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Sep 19, 1995

First use in commerce: Sep 19, 1995

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

13 events

CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9

Nov 21, 2008

CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9

CASE FILE IN TICRS

Apr 03, 2007

CASE FILE IN TICRS

TEAS CHANGE OF CORRESPONDENCE RECEIVED

May 21, 2004

TEAS CHANGE OF CORRESPONDENCE RECEIVED

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

Jul 12, 2003

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

TEAS SECTION 8 & 15 RECEIVED

Apr 21, 2003

TEAS SECTION 8 & 15 RECEIVED

REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED

Apr 21, 2003

REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED

REGISTERED-PRINCIPAL REGISTER

Feb 17, 1998

REGISTERED-PRINCIPAL REGISTER

PUBLISHED FOR OPPOSITION

Nov 25, 1997

PUBLISHED FOR OPPOSITION

NOTICE OF PUBLICATION

Oct 24, 1997

NOTICE OF PUBLICATION

APPROVED FOR PUB - PRINCIPAL REGISTER

Jan 13, 1997

APPROVED FOR PUB - PRINCIPAL REGISTER

CORRESPONDENCE RECEIVED IN LAW OFFICE

Dec 05, 1996

CORRESPONDENCE RECEIVED IN LAW OFFICE

NON-FINAL ACTION MAILED

Jun 11, 1996

NON-FINAL ACTION MAILED

ASSIGNED TO EXAMINER

Jun 06, 1996

ASSIGNED TO EXAMINER

DESIGNING THE FUTURE IN PHARMACEUTICALS

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Genzyme Corporation

Other Marks in Class 042 — Scientific, technology & SaaS services

Other Marks by William G. Gosz

Industries

USPTO Deadlines

Compare

Resources

Company